Akeso

We track 1 ClinicalTrials.gov studies led by Akeso. The portfolio skews toward Phase 3 (1 trials).

1 clinical trials sponsored by Akeso.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
100%

Trial Status Breakdown

Trials by Akeso

A Randomized, Double-blind, Multicenter Phase 3 Clinical Trial of Ivonescimab Versus Placebo, Combined With Docetaxel in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) That Has Progressed on or After PD-(L)1 Inhibitor-based Therapy

NCT06928389 · RECRUITING · Phase 3

Frequently Asked Questions

How many clinical trials does Akeso sponsor?

Akeso currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 3.

What conditions does Akeso research?

Akeso conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Akeso recruiting for clinical trials?

Yes, Akeso currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More